A recent report from the Kaiser Family Foundation found that inital concern over Medicare Advantage enrollment decreasing due to healthcare reform is unfounded. Rates of enrollment have actually increased:
Despite concern that the healthcare reform law would dampen Medicare Advantage enrollment, the opposite has happened so far, according the Kaiser Family Foundation.
Between the beginning of 2012 and March 2013, 1 million more beneficiaries enrolled in the program, a nearly 10% year-over-year increase, bringing total Medicare Advantage enrollment to 14.4 million this year, according to a new report by Kaiser and Mathematica Policy Research. Since 2009, enrollment in MA had grown 30%.
Under the Patient Protection and Affordable Care Act, Medicare payments to Advantage plans last year began to depend on the correlation between their bids and fee-for-service costs in individual counties, though payments to plans can also increase based on quality of service provided. While 2011 payments were held at 2010 levels, the maximum amount a plan could be paid by Medicare began to go down in 2012.
The Kaiser and Mathematic researchers found that the changes didn't negatively affect enrollment in Advantage plans. “There is little evidence of an adverse effect on enrollment in low- versus high-cost counties,” the study says.
Read the full story here: http://bit.ly/19ZwwHo
Source: Modern Healthcare
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More